Company Filing History:
Years Active: 2021-2025
Title: Jiuqiao Zhao: Innovator in Monoclonal Antibodies
Introduction
Jiuqiao Zhao is a prominent inventor based in Newton, MA (US), known for his significant contributions to the field of biotechnology. He holds two patents that focus on the development of monoclonal antibodies, which have important applications in treating various diseases.
Latest Patents
Zhao's latest patents include innovative isolated monoclonal antibodies that specifically bind to human CD152, also known as CTLA-4. These antibodies are designed to be used in methods for treating diseases, including cancers and autoimmune disorders. The patents detail the processes for making these antibodies and their potential therapeutic uses, showcasing Zhao's commitment to advancing medical science.
Career Highlights
Throughout his career, Jiuqiao Zhao has worked with notable companies, including Harbour Biomed (Shanghai) Co., Ltd. and Harbour Biomed Co., Ltd. His work in these organizations has contributed to the development of cutting-edge biopharmaceuticals.
Collaborations
Zhao has collaborated with talented individuals in his field, including coworkers Xin Gan and Yun He. These partnerships have likely enhanced his research and innovation efforts.
Conclusion
Jiuqiao Zhao's work in developing monoclonal antibodies represents a significant advancement in biotechnology. His patents and collaborations reflect his dedication to improving treatments for serious health conditions.